Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 545 M554 M541 M573 M 2.21 B Research & development 242 M251 M237 M261 M 991 M Operating income 309 M399 M434 M532 M 1.67 B Non-Operating Income, Total -5 M-6 M-1 M-14 M -26 M Interest expense, net of interest capitalized 29 M26 M26 M28 M 109 M Non-Operating Income, excl. Interest Expenses 7 M1 M-1 M-3 M 4 M Unusual income/expense -12 M-7 M0-11 M -30 M Pretax income 304 M393 M433 M518 M 1.65 B Equity in earnings ———— — Taxes 71 M88 M99 M114 M 372 M Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations 233 M305 M334 M404 M 1.28 B Discontinued operations ———— — Net income 233 M305 M334 M404 M 1.28 B Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 233 M305 M334 M404 M 1.28 B Basic earnings per share (Basic EPS) 1.161.531.692.03 6.41 Diluted earnings per share (Diluted EPS) 1.151.511.672.02 6.35 Average basic shares outstanding 201 M199 M198 M199 M — Diluted shares outstanding 203 M202 M200 M201 M — EBITDA 315 M405 M439 M553 M 1.71 B EBIT 309 M399 M434 M532 M 1.67 B Cost of revenue 461 M478 M504 M583 M 2.03 B Other cost of goods sold ———— — Depreciation & amortization (cash flow) 6 M6 M5 M21 M 38 M